Dermatological Oncology

It is estimated that 1 in 52 men and 1 in 77 women in the US will be diagnosed with melanoma in their lifetime. Despite the fact that melanoma is one of the most rapidly increasing forms of human cancer, new treatments have been slow in developing and the mortality rate continues to rise. We now know that there are several well-defined risk factors for this form of cancer. Our report contains quantitative and qualitative analytical content, covering the present and future of the global cancer drugs market. Although our report is market-centered, we include medical and technical information. We include analyses of under-met market needs from the present looking forward.

GMR Data forecast that Avastin will reach its financial peak by 2018 before losing its patent exclusivity in 2019. The drug is also set to benefit from a potential combination therapy, with EGFL7, for the treatment of colorectal and lung cancer, similar to that of Herceptin and Perjeta.

  • Advances in Treatment Methods
  • Advances in Diagnostic Procedures
  • Advances in Skin Cancer Research
  • Melanoma
  • Actinic keratosis

Related Conference of Dermatological Oncology

March 1-3, 2018

17th European Dermatology Congress

Paris, France
May 09-10, 2018

19th World Dermatology 2018

Tokyo, Japan
July 12-13, 2018

EuroSciCon Conference on Neurology

Paris, France
July 11-12, 2018

Dermatology Conference 2018

Sydney, Australia
August 16-17, 2018 -

Asia-Pacific Dermatology and Cosmetology Conference

Tokyo, Japan
July 23-24, 2018

13th Global Dermatologists Congress

Moscow, Russia
September 28-29, 2018
(10 Plenary Forums-1 Event)

15th International Conference on Clinical and Experimental Dermatology

San Antonio, Texas
November 02 - 04, 2018

10th Clinical Dermatology Congress

San Francisco, USA

Dermatological Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in